The Next Web
ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports
ByteDance closed a $290M funding round for Anew Labs, its newly spun-off AI drug discovery unit, at a $1.5B valuation, Reuters reports, citing two sources familiar with the matter. Moreover, the company that owns TikTok will retain 56% of…
View original source — The Next Web ↗
Related stories
The Next Web
TechnologySep 3, 2026 · 1 min
ByteDance raises $29.6bn, Asia’s second-biggest loan this year, and pays less for it
The Next Web
Bloomberg
BusinessSep 3, 2026 · 1 min
ByteDance Gets $30 Billion Loan, Asia’s Second-Largest This Year
Bloomberg
Bloomberg
BusinessSep 2, 2026 · 1 min
Lyte Closes $165 Million Round, Bringing AI Startup's Valuation to $1.6 Billion
Bloomberg
Bloomberg
BusinessSep 14, 2026 · 1 min
ICBC, HSBC Among Major Lenders on ByteDance’s $30 Billion Loan
Bloomberg